Skip to content
NumedicusNumedicus
  • Home
  • About
  • Strategy
  • Portfolio
  • Blog
  • Contact
Clinical trial, Rett syndrome

Rett Syndrome treatment receives Orphan Designation

Posted on July 12, 2018May 1, 2020 by admin
12
Jul
Numedicus is pleased to announce that its treatment for Rett Syndrome, licensed to AMO Pharma has successfully received Orphan Drug designation. Full details are found here.
This entry was posted in Clinical trial, Rett syndrome. Bookmark the permalink.
admin

License and collaboration deal with AMO Pharma
What you pay is what you get
About

World class drug repurposing. Based in Cambridge, England. Serving the world.

Latest Posts
  • 28
    Nov
    What you pay is what you get Comments Off on What you pay is what you get
  • 12
    Jul
    Rett Syndrome treatment receives Orphan Designation Comments Off on Rett Syndrome treatment receives Orphan Designation
  • 26
    Jul
    License and collaboration deal with AMO Pharma Comments Off on License and collaboration deal with AMO Pharma
  • 18
    Jul
    Cachexia development enters new phase Comments Off on Cachexia development enters new phase
  • 06
    Jun
    The Empowerment of the Rare Disease Patient Comments Off on The Empowerment of the Rare Disease Patient
Tag Cloud
fibromyalgia kinase inhibitors pricing repurposing
Categories
  • Cachexia (2)
  • Clinical trial (3)
  • Licensing (1)
  • Pricing (1)
  • Rett syndrome (2)
  • Style (5)
  • Uncategorized (3)
Archives
  • November 2018 (1)
  • July 2018 (1)
  • July 2017 (2)
  • June 2017 (1)
  • May 2014 (1)
  • November 2013 (1)
  • September 2013 (1)
  • July 2013 (1)
  • March 2013 (1)
  • December 2012 (1)
  • July 2012 (1)
  • May 2012 (2)
  • April 2012 (2)
  • January 2012 (1)
  • December 2011 (1)
  • December 2010 (1)
  • April 2010 (1)
  • March 2010 (1)
  • December 2009 (1)
  • August 2009 (1)
  • June 2009 (3)
  • May 2009 (2)
  • Home
  • About
  • Strategy
  • Portfolio
  • Blog
  • Contact
Copyright 2024 © Numedicus. All right reserved
  • Home
  • About
  • Strategy
  • Portfolio
  • Blog
  • Contact
    • WooCommerce not Found